SE7409158L - Sett att framstella 3,20-dioxo-16Ÿ-metyl-pregna-1,4,9(11)-triener. - Google Patents

Sett att framstella 3,20-dioxo-16Ÿ-metyl-pregna-1,4,9(11)-triener.

Info

Publication number
SE7409158L
SE7409158L SE7409158A SE7409158A SE7409158L SE 7409158 L SE7409158 L SE 7409158L SE 7409158 A SE7409158 A SE 7409158A SE 7409158 A SE7409158 A SE 7409158A SE 7409158 L SE7409158 L SE 7409158L
Authority
SE
Sweden
Prior art keywords
trienes
pregna
dioxo
methyl
produce
Prior art date
Application number
SE7409158A
Other languages
English (en)
Swedish (sv)
Inventor
J Prost-Marecahl
G Tomasik
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE7409158L publication Critical patent/SE7409158L/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7409158A 1973-07-27 1974-07-11 Sett att framstella 3,20-dioxo-16Ÿ-metyl-pregna-1,4,9(11)-triener. SE7409158L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7327578A FR2244530B1 (fr) 1973-07-27 1973-07-27

Publications (1)

Publication Number Publication Date
SE7409158L true SE7409158L (sv) 1975-01-28

Family

ID=9123242

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7409158A SE7409158L (sv) 1973-07-27 1974-07-11 Sett att framstella 3,20-dioxo-16Ÿ-metyl-pregna-1,4,9(11)-triener.

Country Status (14)

Country Link
US (1) US3923985A (fr)
JP (1) JPS5830319B2 (fr)
BE (1) BE818155A (fr)
CA (1) CA1029659A (fr)
CH (1) CH594698A5 (fr)
DE (1) DE2436234A1 (fr)
DK (1) DK401974A (fr)
FR (1) FR2244530B1 (fr)
GB (1) GB1480763A (fr)
IE (1) IE40163B1 (fr)
IL (1) IL45344A (fr)
NL (1) NL7410093A (fr)
SE (1) SE7409158L (fr)
ZA (1) ZA744750B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383968A1 (fr) * 1977-03-18 1978-10-13 Roussel Uclaf Procede de preparation d'un steroide16a-methyle
EP3656385A1 (fr) * 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Modulateurs stéroïdiens non hormonaux de nf-kb pour le traitement d'une maladie
WO2011127048A2 (fr) 2010-04-05 2011-10-13 Validus Biopharma MODULATEURS STÉROÏDES NON HORMONAUX DE NF-ĸB POUR LE TRAITEMENT DE MALADIES
CN102603842B (zh) * 2012-02-20 2013-10-23 湖南新合新生物医药有限公司 醋酸氢化可的松或其类似物的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2944070A (en) * 1958-09-08 1960-07-05 Merck & Co Inc Preparation of 16alpha-lower alkyl steroids
GB935611A (en) * 1958-12-20 1963-08-28 Syntex Sa New cyclopentanophenanthrene derivatives and process for the production thereof
FR1461655A (fr) * 1965-10-28 1966-02-25 Roussel Uclaf Nouveau procédé de préparation d'un dérivé corticostéroïde et produits obtenus dans ce procédé

Also Published As

Publication number Publication date
US3923985A (en) 1975-12-02
JPS5041847A (fr) 1975-04-16
GB1480763A (en) 1977-07-27
ZA744750B (en) 1975-08-27
FR2244530B1 (fr) 1977-07-01
IL45344A (en) 1978-08-31
AU7165974A (en) 1976-01-29
JPS5830319B2 (ja) 1983-06-28
DE2436234A1 (de) 1975-02-13
FR2244530A1 (fr) 1975-04-18
NL7410093A (nl) 1975-01-29
IE40163B1 (en) 1979-03-28
IL45344A0 (en) 1974-10-22
IE40163L (en) 1975-01-27
BE818155A (fr) 1975-01-27
CA1029659A (fr) 1978-04-18
DK401974A (fr) 1975-04-01
CH594698A5 (fr) 1978-01-31

Similar Documents

Publication Publication Date Title
NO136947C (no) Bredb}ndsrundstr}leantenne.
NL7414096A (nl) Meerinrichting.
DK133480B (da) Underloft.
NL7416189A (nl) Sjabloon.
SE411545B (sv) Sett att framstella chalkonetrar.
SE419606B (sv) Sett att hardloda porosa, jernhaltiga material
NO741792L (no) Prosjektil-tennroer.
NL7409743A (nl) 3,14-gesubstitueerde-8-oxamorfinanen.
SE7409022L (sv) Godselmedel.
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
SE7409151L (sv) 1,3-oxygenerade 8l-ostratriener.
SE7409152L (sv) 1,3-oxygenerade 8l-ostratriener.
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
NL189855C (nl) Oxychloreringswerkwijze.
SE7409158L (sv) Sett att framstella 3,20-dioxo-16Ÿ-metyl-pregna-1,4,9(11)-triener.
NL7411518A (nl) Stoomzeef.
NL7413698A (nl) Bedwelmingstang.
SE419221B (sv) Sett att framstella ftalazion (2,3-b) ftalazin-5,12- dion
NL7403557A (nl) Vorminrichting.
SE385882B (sv) Sett att framstella nya 3,4-dihydropyridoner
SE403285B (sv) Sett att framstella nya 1,4-dihydrokinoliner
SE7513235L (sv) Sett att framstella 1,4-bensodioxaner.
SE7409153L (sv) Sett att framstella 17 b-oxalylsteroider.
NL7410301A (nl) Gesubstitueerde fenylglycylcefalosporinen.
NL7415620A (nl) Vormproces.